beta-lactam
Beta-lactams are the largest family of antibiotics, all sharing one tiny but explosive chemical feature: a strained four-membered ring called the beta-lactam ring. Imagine a coiled spring built into the molecule — when it snaps open against the right bacterial enzyme, it jams that enzyme permanently.
Mechanistically, beta-lactams mimic the natural building block (a D-alanyl-D-alanine end) that bacteria use to cross-link their cell wall. The drug slips into the active site of the enzymes that stitch the wall together (penicillin-binding proteins) and the strained ring acylates a serine in that site, forming a covalent, essentially irreversible bond. With the wall left full of gaps, water rushes in and the bacterium bursts.
The class includes penicillins, cephalosporins, carbapenems, and monobactams, differing in the ring fused next to the beta-lactam and in the side chains. Their main weakness is honest and important: bacteria fight back with beta-lactamase enzymes that pry the ring open before it can act, which is why many beta-lactams are paired with a beta-lactamase inhibitor.
Amoxicillin is often combined with clavulanic acid, a beta-lactamase inhibitor, so the antibiotic's beta-lactam ring survives long enough to act.
Protecting a reactive ring from enzymatic destruction.
The beta-lactam ring is both the source of activity and the source of instability: the same ring strain that makes it react with the target also makes it vulnerable to chemical and enzymatic opening.